For the third consecutive year, the National Committee for Quality Assurance (NCQA) Data Aggregator Validation program has awarded the Validated Data Stream certification to Manifest MedEx (MX), California’s statewide health information exchange (HIE).
34 million Californians’ health information is shared by the HIE with the entire state. Data quality, integrity, and security are rigorously examined for data streams that get NCQA Data Aggregator Validation.
Validated data flows can make quality measurement more effective. Health plans do not require primary source verification for HEDIS reporting when they disclose data from sources that have undergone Data Aggregator Validation validation.
Healthcare Effectiveness Data and Information System, or HEDIS, measures Establish benchmarks, assist payers and healthcare providers in understanding their existing performance in crucial areas, and organize efforts to enhance quality.
Since Reporting Year 2021, Manifest MedEx has offered validated data, enabling payers like Health Plan of San Joaquin (HPSJ) to maximize HEDIS reporting with verified data and HEDIS data extracts.
Erica Galvez, Chief Executive Officer of Manifest MedEx elaborated on the program in a press release, stating the following: “This program is critical in saving time spent on chart chases for health plans and providers, as well as improving health outcomes and experience for members and patients…Not only does it reduce the burden of HEDIS® reporting, but by improving data accuracy in gaps in care, health plans and providers are better able to identify and provide the care individuals need — like vaccinations and preventive screenings — while avoiding duplicative tests and treatments, which add to overall healthcare costs.”
One of the main factors affecting administrative rates besides the claims data from HPSJ is the combination of NCQA-validated data and data extracted for HEDIS reporting from MX.
Hemoglobin A1c (HbA1c) in the Comprehensive Diabetes Care (CDC) program increased by 16.5 percent during the reporting year of 2022, and the administrative rate for controlling high blood pressure (CBP) increased by 8.2 percent.